anti-TNF alpha chimeric monoclonal antibody (The Center of Molecular Immunology)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-TNF alpha chimeric monoclonal antibody (The Center of Molecular Immunology)
Drug Alias NameTNF alpha mAb (CIM)anti-TNF alpha chimeric monoclonal antibody (The Center of Molecular Immunology)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsCrohn DiseaseArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCuba
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCenter Of Molecular Immunology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCenter Of Molecular Immunology
Active IndicationsN/A
Inactive IndicationsCrohn DiseaseArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A